ACTRN12619000184178尚未招募不适用
Comparison of Immunogenicity of mOPV2 administered as 1-drop or 2-drop oral dose to infants in Mocuba district, Mozambique, 2019
WHO0 个研究点目标入组 360 人开始时间: 2019年2月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 9 Months 至 22 Months（—）
- 性别
- All
入选标准
- •healthy child between 9-22 months of age living in study area
排除标准
- •residence outside of study area
- •known immunodeficiency
研究者
相似试验
已完成
不适用
Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South AfricaPoliomyelitisInfections and InfestationsISRCTN18107202World Health Organization (WHO) (Switzerland)800
已完成
不适用
Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in EgyptPolioInfections and InfestationsISRCTN76316509World Health Organization (WHO) (Switzerland)600
已完成
不适用
Comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliovirus Vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in India (Panacea Biotec Ltd mOPV1 study)PolioInfections and InfestationsISRCTN80143849Panacea Biotec Ltd (India)600
尚未招募
4 期
Immune response to polio vaccine in malnourished and normally nourished Pakistani infantspolio vaccine immunogenecityInfection - Other infectious diseasesPublic Health - Other public healthACTRN12612000259842WHO840
尚未招募
4 期
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatioCTRI/2017/02/007793Panacea Biotec Ltd800